Stay updated on AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Sign up to get notified when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.

Latest updates to the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page
- Check6 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new site revision tag (v3.4.2) is displayed and the general operating-status notice about government funding has been removed, with no changes to trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide notice about a lapse in government funding was added, explaining that information may not be up to date and responses may be delayed. The page shows Revision: v3.4.1 replacing v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded: Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed: Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.SummaryDifference0.2%

- Check62 days agoChange DetectedFooter revision updated from v3.3.3 to v3.3.4; the previous revision reference is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a new Locations section listing Florida and Ohio as study sites. The previous Florida Locations and Ohio Locations entries were removed, and the page revision updated to v3.3.3.SummaryDifference0.3%

Stay in the know with updates to AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK002 for Antihistamine-Resistant Chronic Urticaria Clinical Trial page.